← Back to Search

Corticosteroid

Pred Forte for Pseudophakia

Phase 4
Waitlist Available
Led By Bonnie Henderson, MD
Research Sponsored by Innovative Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

The purpose of this study is to determine if Lotemax eye drops are at least as effective as Pred Forte eye drops, which are the standard of care after cataract surgery.

Eligible Conditions
  • Pseudophakia
  • Cataract Surgery

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Prevention Of Retinal Thickening

Trial Design

2Treatment groups
Active Control
Group I: Pred ForteActive Control1 Intervention
Patients scheduled to undergo phacoemulsification will be randomized in a 1:1 schedule to receive Pred Forte BID for 4 weeks postop. All patients will receive Xibrom BID for one month and Besifloxacin BID for 7 to 10 days postop.
Group II: LotemaxActive Control1 Intervention
patients scheduled to undergo phacoemulsification will be randomized in a 1:1 schedule to receive Lotemax BID for 4 weeks postop. All patients will receive Xibrom BID for one month and Besifloxacin BID for 7 to 10 days postop.

Find a Location

Who is running the clinical trial?

Innovative MedicalLead Sponsor
51 Previous Clinical Trials
2,528 Total Patients Enrolled
1 Trials studying Pseudophakia
30 Patients Enrolled for Pseudophakia
Bonnie Henderson, MDPrincipal InvestigatorOphthalmic Consultants of Boston
William Trattler, MDPrincipal InvestigatorThe Center for Excellence in Eye Care
11 Previous Clinical Trials
6,499 Total Patients Enrolled
1 Trials studying Pseudophakia
30 Patients Enrolled for Pseudophakia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification
2010. "Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01193504.
All > Prevention
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top